SILVERLAKE WEALTH MANAGEMENT LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1966026 WILLISTON, VT

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$307,511

-$32,412 QoQ

Shares Held

2,434

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#1,630

of 2,266 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SILVERLAKE WEALTH MANAGEMENT LLC holds $18,416,385 across 9 Drug Manufacturers - General names. GILD ranks #8 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	25,888	$6,574,775
2	MRK	Merck & Co., Inc.	21,599	$2,775,471
3	ABBV	AbbVie Inc.	10,027	$2,523,194
4	LLY	ELI LILLY & Co	1,793	$2,150,578
5	PFE	Pfizer Inc	80,679	$1,942,750
6	AMGN	Amgen Inc	4,333	$1,569,065
7	BMY	Bristol Myers Squibb Co	6,410	$369,344
8	GILD	Gilead Sciences, Inc. This page	2,434	$307,511

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$307,511	2,434	-0.2%	Shares	Sole	2026-08-06
2026-03-31	$339,923	2,439	+0.2%	Shares	Sole	2026-04-15
2025-12-31	$298,626	2,433	+5.0%	Shares	Sole	2026-01-09
2025-09-30	$257,187	2,317	-8.0%	Shares	Sole	2025-10-28
2025-06-30	$279,170	2,518	+0.2%	Shares	Sole	2025-08-25
2025-03-31	$281,469	2,512	+0.2%	Shares	Sole	2025-04-30
2024-12-31	$231,479	2,506	+0.3%	Shares	Sole	2025-01-27
2024-09-30	$209,516	2,499	-3.3%	Shares	Sole	2024-10-10
2023-12-31	$209,248	2,583	-11.1%	Shares	Sole	2024-01-22
2023-03-31	$241,110	2,906	+0.2%	Shares	Sole	2023-04-13
2022-12-31	$248,879	2,899	-14.6%	Shares	Sole	2023-02-16
2022-09-30	$209,314	3,393	+0.4%	Shares	Sole	2023-04-06
2022-06-30	$208,855	3,379	+0.4%	Shares	Sole	2023-04-06
2022-03-31	$200,049	3,365	-7.2%	Shares	Sole	2023-04-06
2021-12-31	$263,429	3,628	—	Shares	Sole	2023-04-06
No filing history on record for this holder in this stock.